[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xoma Royalty Corporation 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 USA

www.xoma.com Employees: 14 P: 510-204-7200

Sector:

Medical

Description:

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 526,095
Enterprise Value, $K 566,795
Shares Outstanding, K 12,541
Float, K 11,425
% Float 91.10%
Short Interest, K 852
Short Float 6.79%
Days to Cover 8.25
Short Volume Ratio 0.30
% of Insider Shareholders 8.90%
% of Institutional Shareholders 95.92%

Financials:

Annual Sales, $ 52,150 K
Annual Net Income, $ 31,710 K
Last Quarter Sales, $ 12,320 K
Last Quarter Net Income, $ 4,470 K
EBIT, $ 8,290 K
EBITDA, $ 11,260 K

Growth:

1-Year Return 52.77%
3-Year Return 122.08%
5-Year Return 25.98%
5-Year Revenue Growth 77.44%
5-Year Earnings Growth -15.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.17 on 05/12/26
Next Earnings Date 08/12/26
Earnings Per Share ttm 0.42
EPS Growth vs. Prev Qtr 41.67%
EPS Growth vs. Prev Year 183.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/18/16

XOMA Ratios

Ratio
Price/Earnings ttm 100.00
Price/Earnings forward 46.41
Price/Earnings to Growth N/A
Return-on-Equity % 12.56%
Return-on-Assets % 4.11%
Profit Margin % 60.81%
Debt/Equity 0.91
Price/Sales 10.10
Price/Cash Flow 73.67
Price/Book 5.39
Book Value/Share 9.48
Interest Coverage 3.44
60-Month Beta 0.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.